Compositions for treating functional ventricular premature beat and processes for producing the implant

Abstract

The invention provides a traditional medicine composition for treating functionality ventricular pre-beat and making method of implanted agent through dispensing raw material 12-45g lily, 9-27g albizia flower, 0. 3-36g magnet, 6-12g Yejiaoteng, 9-18g white peony root, 6-18g red sage root and 3-18g Zhigancao with weight ratio to form. The making method of implanted agent comprises the following steps: preparing traditional medicine extractive powder; preparing based on surgical catgut as carrier through dispensing raw material 10%-40% traditional medicine extractive powder, 10%-30% nanometer ferrosic oxide, 30%-80% alcohol with 50% percentage by weight concentration and 1%-10% surgical catgut with weight ratio to form; preparing based on polylactic acid-glycollic acid copolymer as carrier through dispensing raw material 50%-98% polylactic acid-glycollic acid copolymer(PLGA), 1%-49% traditional medicine extractive powder, 1%-20% nanometer ferrosic oxide with weight ratio to form. The invention has exact curative effect with reliable pharmacology and without toxic-side effect, the implanted agent has four in one effect of needling, drug, magnet therapy and slow release, which has better effect through adopting implanted agent to co-operate medicinal broth according to condition.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition, in particular to a traditional Chinese medicine composition for treating functional ventricular premature beats, and also relates to a preparation method of the implant. Background technique [0002] Ventricular premature beats are a common arrhythmia (the detection rate of ventricular premature beats in 24-hour dynamic monitoring of the general population is 50%). According to whether there is organic heart disease, it can be divided into functional premature ventricular beats and cardiac arrhythmias. Premature beats due to organic disease, such as premature beats complicated by coronary heart disease. At present, chemically synthesized drugs commonly used in clinical practice to resist premature beats have problems such as toxicity, side effects, and drug resistance caused by long-term medication. Multiple patient options. The focus of existing Chinese medicine prescriptions for t...

AI Technical Summary

Problems solved by technology

At present, the traditional Chinese medicine formulations for the treatment of arrhythmia are mainly taken orally, which requires frequent medication, especially for frequent premature ventricular premature beats, which seriously affects the rest of the patient, so it cannot meet the dosage requirements of premature ventricular premature

In particular, there is a lack of dosage forms that can not only play the role of medicine but also can play the role of acupuncture

[0004] At present, due to the accelerated pace of life, there are more and more arrhythmias without heart disease, that is, there are more and more people with functional premature beats, but there is still a lack of special drugs for the treatment of functional premature beats and can A dosage form that can act both as a drug and as an acupuncture treatment